Skip to main content

Table 4 Pathway enrichment and gene ontology of breast cancer related DEGs

From: Genome-scale meta-analysis of breast cancer datasets identifies promising targets for drug development

Category

Term

Count

p-value

GOTERM_BP_FAT

Positive regulation of cell differentiation

4

3.9 × 10−3

GOTERM_BP_FAT

Gliogenesis

3

4.1 × 10−3

GOTERM_BP_FAT

Rhythmic process

3

6.9 × 10−3

GOTERM_BP_FAT

Cellular lipid metabolic process

4

7.1 × 10−3

GOTERM_BP_FAT

Estrous cycle

2

7.1 × 10−3

GOTERM_BP_FAT

Epithelium development

4

7.4 × 10−3

GOTERM_BP_FAT

Negative regulation of hydrolase activity

3

1.1 × 10−2

GOTERM_BP_FAT

Response to drug

3

1.2 × 10−2

GOTERM_BP_FAT

Regulation of oligodendrocyte differentiation

2

1.2 × 10−2

GOTERM_BP_FAT

Reproductive structure development

3

1.2 × 10−2

GOTERM_BP_FAT

Gland development

3

1.2 × 10−2

GOTERM_BP_FAT

Prostaglandin metabolic process

2

1.3 × 10−2

GOTERM_BP_FAT

Lipid metabolic process

4

1.4 × 10−2

GOTERM_BP_FAT

Neurogenesis

4

1.8 × 10−2

GOTERM_BP_FAT

Prostate gland development

2

1.9 × 10−2

GOTERM_BP_FAT

Positive regulation of cell death

3

2.5 × 10−2

GOTERM_CC_FAT

Extracellular exosome

5

5.9 × 10−3

GOTERM_CC_FAT

Extracellular vesicle

5

6.0 × 10−3

GOTERM_CC_FAT

Membrane-bound vesicle

5

1.5 × 10−2

GOTERM_CC_FAT

Extracellular region

5

3.8 × 10−2

GOTERM_CC_FAT

Extrinsic component of membrane

2

8.8 × 10−2

GOTERM_MF_FAT

Receptor binding

4

2.2 × 10−2

GOTERM_MF_FAT

Enzyme binding

4

3.8 × 10−2

GOTERM_MF_FAT

Protein dimerization activity

3

9.2 × 10−2